Net Cash Provided by (Used in) Operating Activities |
-335K |
USD |
+1.57% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
334K |
USD |
+33.7% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
6.52M |
USD |
-94.1% |
Dec 31, 2023 |
Q4 2023 |
Common Stock, Shares Authorized |
50M |
shares |
0% |
Mar 31, 2023 |
Q1 2023 |
Common Stock, Shares, Issued |
3.43M |
shares |
|
Sep 30, 2022 |
Q3 2022 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2023 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-1.14K |
USD |
+98.7% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
724 |
USD |
-95.6% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
2.08M |
USD |
+117% |
Dec 31, 2023 |
Q4 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Dec 31, 2023 |
Q4 2023 |
Deferred Tax Assets, Gross |
2.08M |
USD |
+117% |
Dec 31, 2023 |
Q4 2023 |
Deferred Federal Income Tax Expense (Benefit) |
-927K |
USD |
-24.9% |
Dec 31, 2023 |
Q4 2023 |
Unrecognized Tax Benefits |
0 |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Additional Paid in Capital |
550K |
USD |
+8.49% |
Mar 31, 2024 |
Q1 2024 |
Current Federal Tax Expense (Benefit) |
187K |
USD |
|
Dec 31, 2022 |
Q4 2022 |
Deferred State and Local Income Tax Expense (Benefit) |
-192K |
USD |
-24.9% |
Dec 31, 2023 |
Q4 2023 |